Published in Lab Business Week, August 12th, 2007
These findings came from a study in a Dublin hospital where over 3000 blood samples were collected from 1100 patients over a 3-year period. The markers were assessed simultaneously using the revolutionary biochip array technology. Miniaturisation of multiple test sites on the biochip surface keeps sample and reagent volume to a minimum and automation of the test on a stand-alone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week